---
title: "European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276465384.md"
description: "European equities traded in the US saw a slight increase, with the S&P Europe Select ADR Index rising 0.1% to 1,845.20, marking a 1.76% gain for the week. Notable gainers included Sequans Communications and DBV Technologies, while Ascendis Pharma and Materialise were among the decliners. In the UK and Ireland, Diageo and Endava led the gains, whereas Biodexa Pharmaceuticals and Trinity Biotech experienced significant declines. MT Newswires does not provide investment advice."
datetime: "2026-02-20T16:11:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276465384.md)
  - [en](https://longbridge.com/en/news/276465384.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276465384.md)
---

# European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday trading

11:11 AM EST, 02/20/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts edged up 0.1% to 1,845.20 on the S&P Europe Select ADR Index late Friday morning. It was up 1.76% for the week.

From continental Europe, the gainers were led by semiconductor firm Sequans Communications ( SQNS ) and biopharmaceutical company DBV Technologies ( DBVT ) , which rose 2.4% and 2% respectively. They were followed by lender ING (ING) and software firm SAP (SAP), which rose 1.7% and 1.5% respectively.

The decliners from continental Europe were led by Ascendis Pharma ( ASND ) and 3D printer company Materialise (MTLS), which fell 2.8% and 2.5% respectively. They were followed by pharmaceutical firm Novo Nordisk ( NVO ) , which was down 2.4%.

From the UK and Ireland, the gainers were led by alcoholic beverage company Diageo ( DEO ) and Endava ( DAVA ) , which advanced 3.6% and 3.4% respectively. They were followed by biopharmaceutical companies Akari Therapeutics ( AKTX ) and NuCana ( NCNA ) , which were up 3.1% and 2.1% respectively.

The decliners from the UK and Ireland were led by Biodexa Pharmaceuticals ( BDRX ) and Trinity Biotech ( TRIB ) , which dropped 7% and 3.1% respectively. They were followed by Bicycle Therapeutics ( BCYC ) , which lost 2%.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [SQNS.US](https://longbridge.com/en/quote/SQNS.US.md)
- [DAVA.US](https://longbridge.com/en/quote/DAVA.US.md)
- [DEO.US](https://longbridge.com/en/quote/DEO.US.md)
- [DBVT.US](https://longbridge.com/en/quote/DBVT.US.md)
- [SPEU.US](https://longbridge.com/en/quote/SPEU.US.md)
- [TRIB.US](https://longbridge.com/en/quote/TRIB.US.md)
- [BDRX.US](https://longbridge.com/en/quote/BDRX.US.md)
- [ASND.US](https://longbridge.com/en/quote/ASND.US.md)
- [MTLS.US](https://longbridge.com/en/quote/MTLS.US.md)

## Related News & Research

- [SEAGRAM'S 7 CROWN BLENDED WHISKEY TURNS UP THE TASTE OF SUMMER WITH NEW APPLE PIE FLAVOR | DEO Stock News](https://longbridge.com/en/news/286422217.md)
- [Diageo's US problems temper third-quarter sales beat](https://longbridge.com/en/news/285330189.md)
- [UK's Endava Q3 revenue falls 8.4% on weak demand, posts goodwill impairment](https://longbridge.com/en/news/287210665.md)
- [Endava plc Stock 12‑Month Price Target Cut to $8.28, Implies 107% Upside](https://longbridge.com/en/news/287263782.md)
- [Endava Q2 Earnings Report: What Investors Need to Know](https://longbridge.com/en/news/276332941.md)